Quick Answer
NEOGENOMICS INC reported Stockholders Equity of $836.56 million for fiscal year 2025.
NEOGENOMICS INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $836.56M | -7.3% |
| 2024 | $902.34M | -4.2% |
| 2023 | $941.54M | -5.7% |
| 2022 | $998.02M | -9.9% |
| 2021 | $1.11B | +59.6% |
| 2020 | $694.29M | +36.8% |
| 2019 | $507.41M | +58.3% |
| 2018 | $320.44M | +86.3% |
| 2017 | $171.96M | +5.9% |
| 2016 | $162.32M | -22.2% |
| 2015 | $208.52M | +245.2% |
| 2014 | $60.41M | +178.2% |
| 2013 | $21.71M | +135.6% |
| 2012 | $9.22M | +56.3% |
| 2011 | $5.90M | +88.1% |
| 2010 | $3.13M | -44.4% |
| 2009 | $5.64M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $838.29M | -7.7% | -1.8% |
| June 30, 2025 | $854.04M | -6.8% | -3.9% |
| March 31, 2025 | $888.27M | -3.8% | -1.6% |
| December 31, 2024 | $902.34M | -4.2% | -0.6% |
| September 30, 2024 | $908.21M | -4.1% | -0.8% |
| June 30, 2024 | $915.88M | -4.2% | -0.8% |
| March 31, 2024 | $923.41M | -5.2% | -1.9% |
| December 31, 2023 | $941.54M | -5.7% | -0.6% |
- NEOGENOMICS INC showed a decrease of -7.3% in Stockholders Equity compared to the prior fiscal year.
- Over the 2009–2025 period, NEOGENOMICS INC’s stockholders equity has grown by 14724.8% (from $5.64 million to $836.56 million).
- The most recent figure is from NEOGENOMICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: